Search results
What Is the Treatment for the COVID-19 Delta Variant? There is currently no cure for COVID-19 (coronavirus disease 2019) and the goal of treatment is to relieve symptoms in mild to moderate cases. Treatment is the same regardless of the infectious variant.
Jun 30, 2021 · What is the delta coronavirus variant? Originally known as B.1.617.2, the delta variant is the most infectious version of the COVID-19 virus to date. It was first identified in India in December 2020, where it quickly overwhelmed that country’s health care system. How widespread is the delta variant in the U.S.?
Sep 22, 2021 · Delta is now the predominant COVID-19 variant – by far – accounting for more than 99% of U.S. cases. And it's no longer a given that you can largely escape COVID-19 infection while...
- What You Need to Know
- What Did The Researchers do?
- Why Is This Research Important?
- Where Can I Go to Learn More?
- Sources
As SARS-CoV-2 — the virus that causes COVID-19 — continues to spread, there is a greater chance that viral variants can develop. “Variants of concern” like Delta (B.1.617.2) and Omicron(B.1.1.529) can be more infectious or cause more serious illness than the original virus. There is much more to learn about how long immunity against SARS-CoV-2 last...
Researchers from around the world established the Coronavirus Immunotherapy Consortium (CoVIC), a collaborative effort to determine which antibodies are most effective against SARS-CoV-2. CoVIC researchers analyzed 269 monoclonal antibodies and mapped where they bind to the SARS-CoV-2 spike protein. The spike protein is an important protein on the ...
Existing monoclonal antibody infusions are an effective treatment for COVID-19, and finding new treatments that work against current and future viral variants is a top priority. The Omicron variant has emerged since this research was completed. That variant has approximately 30 mutations in the spike protein. It is not yet known which monoclonal an...
Coronavirus Immunotherapy Consortium (CoVIC) 1. This global initiative accelerates the discovery, optimization, and delivery of lifesaving antibody-based therapeutics against SARS-CoV-2 and is funded in part by NIAID. NIH COVID-19 Treatment Guidelines: Monoclonal Antibodies 1. NIH’s COVID-19 Treatment Guidelines provide clinicians with evidence-bas...
Hastie, K. M., Li, H., Bedinger, D., Schendel, S. L., Dennison, S. M., Li, K., Rayaprolu, V., Yu, X., Mann, C., Zandonatti, M., Diaz Avalos, R., Zyla, D., Buck, T., Hui, S., Shaffer, K., Hariharan, C., Yin, J., Olmedillas, E., Enriquez, A., Parekh, D., … Saphire, E. O. (2021). Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A...
Aug 10, 2021 · New Preventative Treatment for COVID-19 and the Delta Variant. At a press conference this morning, UPMC experts spoke about the Delta variant of COVID-19, as well as the new prophylactic use of monoclonal antibodies for people who have been exposed to the virus.
- Sarah Katz
Oct 18, 2021 · Some experts believe breakthrough infections are likelier after exposure to the Delta variant than to prior forms of the virus. Even when more recent data becomes available, however, it still...
Jul 9, 2021 · The Centers for Disease Control and Prevention announced July 7 that the highly contagious Delta variant is now the dominant strain of COVID-19, accounting for 51% of new cases in the U.S. The variant, identified as B.1.617.2, originated in India in December and was first detected in the U.S. in March.
